These data collectively suggest that under the instigation of Id1-expressing tumours, the VEGFR1+ cells in the bone marrow were endowed with the capability to stimulate ESCC cells to proliferate and metastasize even before they were recruited into primary tumours and secondary sites. The gene discussed is FLT1; the disease is neoplasm.